drugset / Trial / NCT05135286

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

NCT05135286

Phase 3 Completed 629 enrolled Visus Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

Timeline

Start
2022-03-15
Primary completion
2025-03-13
Completion
2025-03-13

Drugs

EvaluationDrugModalityDoseRoute
Subject BRIMOCHOL Unknown
Comparator CARBAMOYLCHOLINE Small molecule Topical

Indications